1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Insulin Like Growth Factor 1 (IGF-1) Activators -Pipeline Insights, 2016


DelveInsight’s, “Insulin Like Growth Factor 1 (IGF-1) Activators-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Insulin Like Growth Factor 1 (IGF-1) Activators. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Insulin Like Growth Factor 1 (IGF-1) Activators. DelveInsight’s Report also assesses the Insulin Like Growth Factor 1 (IGF-1) Activators therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope
- The report provides competitive pipeline landscape of Insulin Like Growth Factor 1 (IGF-1) Activators
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Insulin Like Growth Factor 1 (IGF-1) Activators pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Insulin Like Growth Factor 1 (IGF-1) Activators and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Table Of Contents

Insulin Like Growth Factor 1 (IGF-1) Activators -Pipeline Insights, 2016

- Insulin Like Growth Factor 1 (IGF-1) Activators Overview
- Insulin Like Growth Factor 1 (IGF-1) Activators Disease Associated
- Insulin Like Growth Factor 1 (IGF-1) Activators Pipeline Therapeutics
- Insulin Like Growth Factor 1 (IGF-1) Activators Therapeutics under Development by Companies
- Insulin Like Growth Factor 1 (IGF-1) Activators Filed and Phase III Products
- Comparative Analysis
- Insulin Like Growth Factor 1 (IGF-1) Activators Phase II Products
- Comparative Analysis
- Insulin Like Growth Factor 1 (IGF-1) Activators Phase I and IND Filed Products
- Comparative Analysis
- Insulin Like Growth Factor 1 (IGF-1) Activators Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Insulin Like Growth Factor 1 (IGF-1) Activators - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Insulin Like Growth Factor 1 (IGF-1) Activators - Discontinued Products
- Insulin Like Growth Factor 1 (IGF-1) Activators - Dormant Products
- Companies Involved in Therapeutics Development for Insulin Like Growth Factor 1 (IGF-1) Activators
- Appendix
- Methodology
- Contact Us
- Disclaimer


List of Tables

- Number of Products under Development for Insulin Like Growth Factor 1 (IGF-1) Activators by Therapy Area, 2016
- Number of Products under Development for Insulin Like Growth Factor 1 (IGF-1) Activators, 2016
- Number of Products under Development by Companies
- Comparative Analysis by Filed and Phase III Products, 2016
- Comparative Analysis Phase II Products, 2016
- Comparative Analysis Phase I and IND Filed Products, 2016
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2016
- Drug Candidates Profiles
- Insulin Like Growth Factor 1 (IGF-1) Activators Assessment by Monotherapy Products
- Insulin Like Growth Factor 1 (IGF-1) Activators Assessment by Combination Products
- Insulin Like Growth Factor 1 (IGF-1) Activators Assessment by Route of Administration
- Insulin Like Growth Factor 1 (IGF-1) Activators Assessment by Stage and Route of Administration
- Insulin Like Growth Factor 1 (IGF-1) Activators Assessment by Molecule Type
- Insulin Like Growth Factor 1 (IGF-1) Activators Assessment by Stage and Molecule Type
- Insulin Like Growth Factor 1 (IGF-1) Activators Therapeutics - Discontinued Products
- Insulin Like Growth Factor 1 (IGF-1) Activators Therapeutics - Dormant Products
- Products under Development by Companies, 2016

List of Figures

- Number of Products under Development for Insulin Like Growth Factor 1 (IGF-1) Activators by Therapy Area, 2016
- Number of Products under Development for Insulin Like Growth Factor 1 (IGF-1) Activators, 2016
- Filed and Phase III Products, 2016
- Phase II Products, 2016
- Phase I and IND Filed Products, 2016
- Discovery and Pre-Clinical Stage Products, 2016
- Insulin Like Growth Factor 1 (IGF-1) Activators Assessment by Monotherapy Products
- Insulin Like Growth Factor 1 (IGF-1) Activators Assessment by Combination Products
- Insulin Like Growth Factor 1 (IGF-1) Activators Assessment by Route of Administration
- Insulin Like Growth Factor 1 (IGF-1) Activators Assessment by Stage and Route of Administration
- Insulin Like Growth Factor 1 (IGF-1) Activators Assessment by Molecule Type
- Insulin Like Growth Factor 1 (IGF-1) Activators Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Europe Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK

2016 Europe Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK

  • $ 12800
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800. VPGMarketResearch’s new report is a study of the major business opportunities emerging in the European cance ...

R&D Drug Pipeline Database: 1-Year Subscription

R&D Drug Pipeline Database: 1-Year Subscription

  • $ 6600
  • Industry report
  • November 2016
  • by La Merie Publishing

R&D Drug Pipeline Database: 1-Year Subscription Subscription to La Merie Publishing’s proprietary R&D Drug Pieline Database provides 24/7 online access to information about more than 21,000 project entries ...

Cancer Vaccines: Technologies and Global Markets

Cancer Vaccines: Technologies and Global Markets

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

This cancer vaccines report by BCC Research explores present and future strategies within the market which includes prophylactic vaccines and therapeutic vaccines. Use this report to: - Analyze the global ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.